首页> 外文期刊>Oncology: International Journal of Cancer Research and Treatment >Plasma d-dimer level as a mortality predictor in patients with advanced or recurrent colorectal cancer
【24h】

Plasma d-dimer level as a mortality predictor in patients with advanced or recurrent colorectal cancer

机译:血浆d-二聚体水平作为晚期或复发性结直肠癌患者死亡率的预测指标

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Plasma D-dimer levels are elevated in patients with a variety of solid tumors. Recently, it has been reported that the level before curative surgery is a prognostic factor for colorectal cancer (CRC). We investigated whether the plasma D-dimer level before systemic chemotherapies is a predictor for advanced or recurrent unresectable CRC. Methods: This study included 42 patients treated with systemic chemotherapies for advanced or recurrent unresectable CRC. Variables including clinicopathological factors, plasma D-dimer levels and the modified Glasgow Prognostic Factor Score (mGPS) were evaluated. Results: The plasma D-dimer level was closely related to the mGPS. Survival was shorter for patients with plasma D-dimer levels >5 μg/ml than for those with lower levels. Compared with an mGPS of 0 or 1, an mGPS of 2 was predictive of poor prognosis (p < 0.0001). Old age, advanced stage, plasma D-dimer level and mGPS were significantly associated with mortality, but plasma D-dimer level was the only independent risk factor in multivariate analysis, and was significant related to the clinical response to chemotherapy (p < 0.05). Conclusions: Survival was significantly shorter in patients with elevated plasma D-dimer levels having advanced or recurrent CRC. The plasma D-dimer level before systemic chemotherapies was an independent mortality predictor.
机译:目的:患有各种实体瘤的患者血浆D-二聚体水平升高。最近,有报道说根治性手术前的水平是结直肠癌(CRC)的预后因素。我们调查了全身化疗前血浆D-二聚体水平是否是晚期或复发性不可切除CRC的预测因子。方法:本研究包括42例因晚期或复发性不可切除CRC接受全身化疗的患者。评估包括临床病理因素,血浆D-二聚体水平和改良的格拉斯哥预后因素评分(mGPS)在内的变量。结果:血浆D-二聚体水平与mGPS密切相关。血浆D-二聚体水平> 5μg/ ml的患者的生存期短于血浆D-二聚体水平较低的患者。与0或1的mGPS相比,mGPS的2预示不良预后(p <0.0001)。老年,晚期,血浆D-二聚体水平和mGPS与死亡率显着相关,但血浆D-二聚体水平是多变量分析中唯一的独立危险因素,并且与化疗的临床反应显着相关(p <0.05) 。结论:血浆D-二聚体水平升高,CRC晚期或复发的患者生存期明显缩短。全身化疗前血浆D-二聚体水平是独立的死亡率预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号